Adults 18 to 65, any sex, with Periapical Periodontitis or Bacterial Infections. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Metabolic Activity of Persistent BacteriaPrimary· After 14 day treatment period
The metabolic activity (rRNA/DNA ratio) of total bacteria, Bacteroidaceae sp. 272, Cutibacterium acnes, Selenomonas spp. and Enterococcus faecalis in root canal samples taken before and after endodontic procedures.
Total bacteria at baseline (S1)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
4.748
± 6.2904
Total bacteria after root canal Preparation (S2)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
2.57
± 3.21
Total bacteria after adjunctive procedures (S3)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
2.614
± 2.978
Total bacteria after intracanal medication (S4)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
4.0008
± 4.374
Total bacteria after 2nd-visit preparation (S5)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
3.7875
± 2.9727
Bacteroidaceae sp. HOT-272 at S1
Group
Value
95% CI
Bacterial Species Analysis After Root Canal Preparation
1.136
± 0.1318
Bacteroidaceae sp. HOT-272 at S2
Group
Value
95% CI
Bacterial Species Analysis After Root Canal Preparation
1.123
± 0.1033
Cutibacterium acnes at S1
Group
Value
95% CI
Bacterial Species Analysis After Root Canal Preparation
1.411
± 0.3693
Bacterial LevelsSecondary· After 14 day treatment period
Quantitative data of total bacteria, Bacteroidaceae sp. HOT-272, Cutibacterium acnes, Selenomonas spp. and Enterococcus faecalis determined by DNA-based qPCR (quantitative polymerase chain reaction).
Total bacteria at baseline (S1)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
178500
6210 – 2520000
Total bacteria after root canal Preparation (S2)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
7580
0 – 835000
Total bacteria after adjunctive procedures (S3)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
3815
0 – 184000
Total bacteria after intracanal medication (S4)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
15550
0 – 209000
Total bacteria after 2nd-visit preparation (S5)
Group
Value
95% CI
Total Bacteria Analysis After 1rst- and 2nd-visit Procedures
0
0 – 96200
Bacteroidaceae sp. 272 at S1
Group
Value
95% CI
Bacterial Species Analysis After Root Canal Preparation
0
0 – 320000
Bacteroidaceae sp. 272 at S2
Group
Value
95% CI
Bacterial Species Analysis After Root Canal Preparation
0
0 – 12300
Cutibacterium acnes at S1
Group
Value
95% CI
Bacterial Species Analysis After Root Canal Preparation
0
0 – 17600
Bacterial Community DiversitySecondary· After 14 day treatment period
Composition of the active microbiome by Next Generation Sequencing (NGS) analysis of the root canal samples.
Firmicutes
Group
Value
95% CI
Bacterial Composition at Baseline
39.7
Bacterial Composition After Root Canal Preparation
39.8
Bacterial Composition After Intracanal Medication
39.8
Bacteroidetes
Group
Value
95% CI
Bacterial Composition at Baseline
39
Bacterial Composition After Root Canal Preparation
39.1
Bacterial Composition After Intracanal Medication
38.6
Proteobacteria
Group
Value
95% CI
Bacterial Composition at Baseline
15.8
Bacterial Composition After Root Canal Preparation
15.7
Bacterial Composition After Intracanal Medication
16
Actinobacteria
Group
Value
95% CI
Bacterial Composition at Baseline
1.4
Bacterial Composition After Root Canal Preparation
1.4
Bacterial Composition After Intracanal Medication
1.6
Spirochaetes
Group
Value
95% CI
Bacterial Composition at Baseline
0.7
Bacterial Composition After Root Canal Preparation
0.7
Bacterial Composition After Intracanal Medication
0.6
Endodontic SuccessSecondary· 1 year after endodontic treatment
Absence of clinical signs/ symptoms and reduction/ absence of apical radiolucency in radiologic examination
Group
Value
95% CI
Root Canal Preparation and Medication
19
Sponsor's own description
This study aims to evaluate an endodontic treatment protocol using adjunctive steps for disinfection of teeth with primary endodontic infections.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT03680534 — 3D Analysis of Root Canal Conformation
· NA
· completed
Other recruiting trials for Periapical Periodontitis
Currently open trials in the same condition.
NCT07501585 — Hyaluronic Acid in Endodontic Microsurgery
· NA
· recruiting
NCT07252258 — Comparison of Frequency of Calcium Hydroxide Mixed With 0.2% Chlorhexidine Versus Saline as Intracanal Medicament in Per
· NA
· active not recruiting
NCT07019298 — Success of Endodontic Treatment With Different Obturation Techniques and Sealer Cements
· NA
· recruiting
NCT07018284 — Postoperative Pain Evaluation After Obturation With Different Sealers
· NA
· recruiting
NCT07026435 — Comparison of LSTR and Pulpectomy in Primary Molars of Pediatric Patients (LSTR-PULP)
· NA
· active not recruiting
Other University of Sao Paulo trials
Trials by the same sponsor.
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet
· NA
· recruiting
NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial
· NA
· active not recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters
· NA
· active not recruiting
NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi
· completed
NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
Last refreshed: 8 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03537664.